Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PULSE BIOSCIENCES, INC. Director's Dealing 2025

Aug 20, 2025

32093_dirs_2025-08-19_bbe1788c-58e8-4aa9-a08e-bf1123cc772f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PULSE BIOSCIENCES, INC. (PLSE)
CIK: 0001625101
Period of Report: 2025-08-15

Reporting Person: DUGGAN ROBERT W (Director, 10% Owner)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2025-08-15 Stock Option (right to buy) $16.16 A 30000 Acquired 2035-08-15 Common Stock (30000) Direct
2025-08-15 Stock Option (right to buy) $16.16 A 20792 Acquired 2035-08-15 Common Stock (20792) Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 15, 2025.

F2: The shares subject to the option will vest in equal quarterly installments over a one-year period, subject to the Reporting Person's continued service through each vesting date, with the first such installment occurring on September 5, 2025.